1. Home
  2. AFG vs KRYS Comparison

AFG vs KRYS Comparison

Compare AFG & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Financial Group Inc.

AFG

American Financial Group Inc.

HOLD

Current Price

$143.43

Market Cap

11.7B

Sector

Finance

ML Signal

HOLD

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$335.33

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AFG
KRYS
Founded
1872
2015
Country
United States
United States
Employees
8500
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
10.3B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
AFG
KRYS
Price
$143.43
$335.33
Analyst Decision
Hold
Strong Buy
Analyst Count
4
11
Target Price
$141.00
$297.60
AVG Volume (30 Days)
385.2K
531.0K
Earning Date
04-29-2026
05-04-2026
Dividend Yield
2.72%
N/A
EPS Growth
N/A
128.00
EPS
N/A
1.83
Revenue
N/A
$389,130,000.00
Revenue This Year
N/A
$38.74
Revenue Next Year
$4.44
$32.53
P/E Ratio
$12.86
$178.69
Revenue Growth
N/A
33.94
52 Week Low
$122.11
$130.50
52 Week High
$150.02
$382.54

Technical Indicators

Market Signals
Indicator
AFG
KRYS
Relative Strength Index (RSI) 59.56 43.97
Support Level $128.04 $246.17
Resistance Level $144.74 $382.33
Average True Range (ATR) 2.52 17.52
MACD -0.22 -5.71
Stochastic Oscillator 73.51 21.50

Price Performance

Historical Comparison
AFG
KRYS

About AFG American Financial Group Inc.

American Financial Group Inc is an insurance holding company. Through its subsidiaries, it is engaged in the property and casualty insurance business, focusing on specialized commercial products for businesses. The group operates through two segments: Property and Casualty Insurance, which generates maximum revenue, and Other. The Property and Casualty Insurance segment is further divided into different sub-segments, such as Property and transportation, Specialty casualty, and Specialty financial. These sub-segments offer insurance coverage for vehicles and commercial property, customized programs for small to mid-sized businesses, workers' compensation insurance, risk management insurance programs for lending and leasing institutions, trade credit insurance, and other insurance products.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: